Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotorasib versus docetaxel in previously treated KRAS G12C-mutated advanced non-small cell lung cancer
jRCT2080225266Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2020
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of sotorasib in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Amgen. Started Jul 2020; status: completed.
02
Drugs
sotorasib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCT2080225266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225266.